After 28 days of use, discard the vial even if medication remains inside, because the rubber stopper exposure allows bacterial growth and oxidation
Clinical trials have demonstrated that semaglutide can reduce hemoglobin A1c by 1.52.0% in patients with type 2 diabetes (SUSTAIN clinical trial program) and produce weight loss of 1015% of body weight over 68 weeks in obesity treatment (STEP clinical trial program)
These numbers are higher than at any previous dose level
Healthcare professionals in the UK consistently advise against combining prescription weight management medicines with unregulated dietary supplements without explicit medical supervision
Additionally, there are patient assistance programs offered by the manufacturer, as well as discounts and coupons available through various channels that can help reduce the out-of-pocket expenses
Improved Insulin Sensitivity : GLP-1 receptor agonists improve insulin sensitivity, allowing the body to use glucose more efficiently, which in turn prevents fat storage and encourages fat utilization for energy